Demetrios Louis, MD
Pain Medicine · Arlington Heights, ILNPI 1477709442
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 51 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations.
Across 360 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$1K
- Collegium Pharmaceutical, Inc.$779
- Medtronic$467
- AbbVie$390
- Fidia Pharma USA Inc.$281
- plus $3K from 45 others
What the payments were for
- Travel & lodging$1702%
- Food & beverage$7,74897%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,993 in reported general payments places this provider in the 75th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 35 | $29,400 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 160 | $2,620 |
| Gabapentin | 238 | $2,153 |
| Fentanyl | 16 | $1,695 |
| Baclofen | 144 | $1,486 |
| Pregabalin | 134 | $1,344 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 54 | $1,218 |
| Oxycodone Hcl | 46 | $478 |
| Cyclobenzaprine Hcl | 51 | $469 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $467 |
| Morphine Sulfate | 22 | $447 |
| Tramadol Hcl | 53 | $298 |
| Duloxetine Hcl | 26 | $274 |
| Hydromorphone Hcl | 24 | $223 |
| Meloxicam | 40 | $170 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Arlington Heights
- George MacriniciArlington Heights$14K
- Yuriy BukhaloArlington Heights$13K
- Paul MarsigliaArlington Heights$12K
- Mohammad AhsanArlington Heights$9K
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Thomas DahlbergRockford$218K
- Steven CohenChicago$217K
- Albert SinghQuincy$212K
- Nirav ShahSkokie$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.